Time to focus on prevention efforts

Europe’s vaccination policies face a critical moment. A December 2025 workshop in Brussels will gather researchers, patient advocates, and civil society leaders to explore the next frontiers of vaccine development.

Prevention as a public good

Mariano Votta and Daniela Quaggia of the Active Citizenship Network say vaccination research extends beyond developing new products. It involves creating policies that protect communities. Their group, the EU branch of Italian NGO Cittadinanzattiva, has long campaigned for lifelong immunization across Europe. This time, they aim to improve transparency and patient involvement in research.

The event will address three key topics: vaccine development stages, new technologies like mRNA and DNA platforms, and a system for returning individual data to clinical trial participants. The last point builds on the FACILITATE project, an Innovative Health Initiative (IHI) project to let study volunteers access their own results. The approach aims to build trust by showing people how their participation advances science.

The workshop’s organizers hope to change the conversation. Rather than just warning about future risks, they want to emphasize existing progress—such as vaccines that prevent millions of deaths each year.

Funding and public trust

The timing aligns with the EU’s next long-term budget discussions. A coalition of experts, including the Active Citizenship Network, is urging dedicated funding for immunization programs. Their case is clear: prevention benefits both health and the economy.

Professor Walter Ricciardi, who leads the Mission Board on Vaccination in Europe, stated, “Vaccination is one of the most effective tools available. It saves lives, boosts economies, and helps societies recover from crises.” The board’s proposal supports the European Charter of Patients’ Rights, which ensures access to preventive care and innovation without financial barriers.

The event is invitation-only, targeting leaders of patient advocacy groups from across the EU. Organizers recognize the challenge. Public attention fades quickly, and funding decisions move slowly. Yet they also know prevention saves lives and reduces costs over time.

The focus stays on Brussels for now. The workshop won’t feature major announcements. Instead, it aims to shift how vaccination is viewed—as a shared responsibility, not just a medical procedure. If successful, the impact could extend well beyond the conference room.